Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells

Biomedicine and Pharmacotherapy

Volumn 67, Issue 1, 2013, Pages 7-16

  De Santis, Elena ^a   Di Vito, Maura ^a   Perrone, Giulietta Anna ^b   Mari, Emanuela ^a   Osti, Maria ^c   De Antoni, Enrico ^d   Coppola, Luigi ^b   Tafani, Marco ^a,d   Carpi, Angelo ^e   Russo, Matteo A ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Hypoxia; Laser capture microdissection; Pro inflammatory genes; SOCS 1; Thyroid needle aspirate; Thyroid papillary carcinoma

Indexed keywords

GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADULT; ARTICLE; CANCER GROWTH; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIC CELL; INFLAMMATION; LASER CAPTURE MICRODISSECTION; LEUKOCYTE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

ADULT; BIOPSY, FINE-NEEDLE; BLOTTING, WESTERN; CARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; LASER CAPTURE MICRODISSECTION; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; THYROID NEOPLASMS; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84873088029     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.08.003     Document Type: Article

References (37)

1. Chen A.Y., Jemal A., Ward E.M. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009, 115:3801-3807.
2. Greco A., Borrello M.G., Miranda C., Degl'Innocenti D., Pierotti M.A. Molecular pathology of differentiated thyroid cancer. Q J Nucl Med Mol Imaging 2009, 53:440-453.
3. Kimura E.T., Nikiforova M.N., Zhu Z., Knauf J.A., Nikiforov Y.E., Fagin J.A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 2003, 63:1454-1457.
4. V600E mutation influences hypoxia-inducible factor-1α expression levels in papillary thyroid cancer. Mod Pathol 2010, 23:1052-1060.
5. Neely R.J., Brose M.S., Gray C.M., et al. The RET/PTC-3 oncogene activates classical NF-kB by stabilizing NIK. Oncogene 2011, 30:87-96.
6. Burrows N., Resch J., Cowen R.L., et al. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocr Relat Cancer 2010, 17:61-72.
7. Semenza G.L. Oxygen omeostasis. Wiley Interdiscip Rev Syst Biol Med 2010, 2:336-361.
8. Liao D., Johnson R.S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007, 26:281-290.
9. Sullivan R., Graham C.H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 2007, 26:319-331.
10. Semenza G.L. HIF-1O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 2001, 107:1-3.
11. Semenza G.L. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 2008, 60:591-597.
12. Taylor C.T., Cummins E.P. The role of NF-kappaB in hypoxia-induced gene expression. Ann NY Acad Sci 2009, 1177:178-184.
13. Eltzschig H.K., Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011, 364:656-665.
14. Rius J., Guma M., Schachtrup C., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
15. Karin M., Lin A. NF-kB at the crossroads of the life and death. Nature Immunology 2002, 3:221-227.
16. Min C., Eddy S.F., Sherr D.H., Sonenshein G.E. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 2008, 104:733-744.
17. Karin M. Nuclear factor-kB in cancer development and progression. Nature 2006, 44:431-436.
18. Liu Y., Xiao Y., Li Z. P2X7 receptor positively regulates MyD88-dependent NF-kB activation. Cytokine 2011, 55:229-236.
19. Ravenna L., Sale P., Di Vito M., et al. Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate 2009, 69:1245-1255.
20. Tafani M., Russo A., Di Vito M., et al. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma micro-environment. Cancer Sci 2010, 101:1014-1023.
21. Tafani M., Di Vito M., Frati A., et al. Pro-inflammatory gene expression in solid glioblastoma micro-environment and in hypoxic stem cells from human glioblastoma. J Neuroinflammation 2011, 8:32.
22. Chung H.Y., Sung B., Jung K.J., Zou Y., Yu B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal 2006, 8:572-581.
23. Chung H.Y., Cesari M., Anton S., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009, 8:18-30.
24. Strebovsky J., Walker P., Lang R., Dapke A.H. Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. FASEB J 2011, 25:863-874.
25. Ruland J. Return to homeostasis: down-regulation of NF-kB responses. Nature Immunol 2011, 12:709-714.
26. Di Vito M., De Santis E., Perrone G.A., et al. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser-capture microdissection and molecular biology. Canc Sc 2011, 102:1921-1927.
27. Fabien N., Fusco A., Santoro M., Barbien Y., Dubois P.M., Paulin C. Description of a human papillary thyroid carcinoma cell line. Morphology study and expression of tumoral markers. Cancer 1994, 73:2206-2212.
28. Burrows N., Babur M., Resch J., Williams K.J., Brabant G. Hypoxia-inducible factor in thyroid carcinoma. J Thyroid Res 2011, 2011:762905.
29. Arulkumaran N., Unwin R.J., Tam F.W. A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 2011, 20:897-915.
30. Solini A., Cuccato S., Ferrari d, et al. Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease?. Endocrinology 2008, 149:389-396.
31. Tafani M., Schito L., Pellegrini L., Hypoxia-increased RAGE, et al. and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of Nf-kB. Carcinogenesis 2011, 32:1167-1175.
32. Hara A., Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004, 108:43-48.
33. Francipane M.G., Eterno V., Spina V., et al. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy. Cancer Res 2009, 69:6141-6148.
34. Tai K.Y., Shieh Y.S., Lee C.S., Shiah S.G., Wu C.W. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kB and Brg-1. Oncogene 2008, 27:4044-4055.
35. Baldini E., Toller M., Graziano F.M., et al. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid 2004, 14:881-888.
36. Kim H.G., Kim J.Y., Han E.H., et al. Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett 2011, 585:421-428.
37. Chou Y.C., Sheu J.R., Chung Cl, et al. Nuclear-targeted inhibition of NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells. Chem Biol Interact 2010, 184:403-412.